Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 19, 2017
Viagra Cost Online

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

11/19/17 - Agile Therapeutics Presents Additional Phase 3 SECURE Trial Results for Twirla at the American Society for Reproductive Medicine ASRM Scientific...
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Agile Therapeutics, Inc.,, a women's healthcare company, announced additional data from its Phase 3 SECURE trial of Twirla , an investigational, once-weekly, low-dose hormonal contraceptive patch, which showed women experienced mean decreases in length of bleeding and spotti
11/19/17 - Commissioners to vote on contract with sheriff's employees [The Repository, Canton, Ohio]
Nov. 19 CANTON Stark County commissioners could finalize a contract this week with the county sheriff's lieutenants and captains, after approving contracts this year with the three other unions representing sheriff's employees. The commissioners are scheduled to vote Wednesday on a tentative agreement between the sheriff and the Fraternal Order
11/19/17 - Findings from Massachusetts General Hospital Update Understanding of Clinical Trial Research (Comparing the effectiveness of two different decision...
Findings from Massachusetts General Hospital Update Understanding of Clinical Trial Research. By a News Reporter-Staff News Editor at Heart Disease Weekly Data detailed on Clinical Trial Research have been presented. According to news reporting from Boston, Massachusetts, by NewsRx journalists, research stated, "Decision aids have been shown to i
11/19/17 - In The Spotlight: Catalyst Pharmaceuticals
WASHINGTON- Shares of Catalyst Pharmaceuticals Inc. are up an impressive 179% year-to-date while the iShares NASDAQ Biotechnology Index ETF has gained just 17% during the same period. In return, BioMarin made a $5 million investment in Catalyst. But after a preliminary review, the FDA determined that the NDA for Firdapse was not sufficiently comple
11/19/17 - New gene therapy a breakthrough in cancer treatment
Q Our daughter was successfully treated for leukemia as a child, but the chemotherapy she went through was pretty brutal. Now I ve read that we have the first gene therapy for cancer, which is a huge deal. Kymriah is the first gene therapy to be approved by the Food and Drug Administration.
11/19/17 - Pill With Sensor Raises Ethical Concerns About Patient Privacy
The first drug with a sensor embedded in a pill that alerts doctors when patients have taken their medications was approved by the Food and Drug Administration, raising issues involving privacy, cost and whether patients really want caregivers looking over their shoulders. Japan s Otsuka Pharmaceutical Co. will insert a tiny chip the size of
11/19/17 - Study Findings on Anxiety Disorders Are Outlined in Reports from University Hospital of North Norway (Changes in symptoms of anxiety and depression...
Study Findings on Anxiety Disorders Are Outlined in Reports from University Hospital of North Norway. By a News Reporter-Staff News Editor at Heart Disease Weekly Research findings on Mental Health Diseases and Conditions- Anxiety Disorders are discussed in a new report. Our news journalists obtained a quote from the research from the University
11/19/17 - To prevent gun deaths, we must care for mentally ill
Apparently, policy makers are inept at figuring out legislation worthy of safety and well-being for all Americans. The U.S. has never treated gun deaths as a preventable public health problem. Researchers say the matter speaks to U.S. failure to establish introspective, accessible, affordable health care with a strong focus on mental illness.
11/19/17 - White House would ditch attack on Obamacare in order to pass tax bill
The White House is willing to sacrifice Republicans latest attempt to dismantle Obama s Affordable Care Act if that s necessary to pass a series of sweeping tax cuts, Office of Management and Budget director Mick Mulvaney said on Sunday. House& Senate for working so hard on cutting taxes{& reform.} We re getting close! If it becomes
11/18/17 - Area hospitals making adjustments amid national shortage of IV fluids
Supplies, particularly of small bags of solutions, took another hit, however, as a result of Hurricane Maria's impact on manufacturing plants in Puerto Rico. The U.S. Food and Drug Administration announced that it was working with the manufacturer affected by the storm to temporarily import supplies from plants in Ireland, Australia, Canada, Mexico
11/18/17 - Attorney General Kilmartin Presents $1.5 Million Check to Executive Office of Health & Human Services for Medicaid Budget
Attorney General Peter F. Kilmartin today presented a check for $1,505,081.43 to the Executive Office of Health and Human Services, which represented the state's share of a qui tam settlement previously entered into between the State and Mylan, Inc. and Mylan Specialty, LP. Mylan Inc. is a Pennsylvania corporation with its principal place of busine
11/18/17 - Cardiac Surgery Instruments Market 2017: Business Analysis & Professional Surv: Global Cardiac Surgery Instruments Market - An Overall Industry Analysis
Portland, OR 11/17/2017 Progressive Markets added a report, " Cardiac Surgery Instruments Market- Size, Trend, Share, Opportunity Analysis& Forecast, 2014-2025" which says that the global cardiac surgery instruments market is expected to grow at a CAGR of 3.2% from 2017 to 2025.. As the number of people affected by heart problems is growing d
11/18/17 - Cardiovascular Device Market 2016-2023 Forecast Analysis Report By DecisionDatabases
The Cardiovascular Device Market Research Report by DecisionDatabases.Cardiovascular Device provides industry analysis and evaluates the prospective market Size, Share, Growth, Trends and Forecast Till 2023. The report on global cardiovascular device...
11/18/17 - Defense Authorization Bill Conferees Issue Report - Title VII (Health Care Provisions) (Reports and Other Matters)
The conference report was issued on legislation to authorize appropriations for fiscal 2018 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year. The report was advanced by Rep. Mac Thornberry, R- Texas,
11/18/17 - Dental Prosthetics Market World Sensational Growth by Key Players Share and Revenue Forecasts To 2023
"Market Research Futurern" The Dental Prosthetics Market report summarized by Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer.. The World Dental Prosthetics Market report summari
11/18/17 - DHS appoints new Iowa Medicaid director
DES MOINES| Michael Randol has been appointed to direct Iowa's Medicaid Enterprise, officials with the state Department of Human Services announced Friday. He holds a master of business administration degree from William Woods University with an emphasis on finance, as well as a bachelor of science degree in accounting from the University of the St
11/18/17 - DHS appoints new Iowa Medicaid director [Palestine News Agency (WAFA)]
Michael Randol has been appointed to direct Iowas Medicaid Enterprise, officials with the state Department of Human Services announced Friday. He holds a master of business administration degree from William Woods University with an emphasis on finance, as well as a bachelor of science degree in accounting from the University of the State of New Yo
11/18/17 - Discover the Future of "Social Pharma," Only at SMi's Social Media in the Pharmaceutical Industry
Returning to London this January 2018, Day 1 will address topics on wearable technologies, patient engagement and social media strategies; while Day 2 covers interaction using social media, digital health strategies and effective content. www.social-media-pharma.com/prc 3 Key Social Media Priorities for the Pharmaceutical Industry 1.
11/18/17 - EDITORIAL: Clever tactic to kill Obamacare [The News Herald, Panama City, Fla.]
Nov. 18 Despite their inability to fulfill their voters' wishes earlier this year, congressional Republicans might have finally found a way to undo the Affordable Care Act and if successful, they may have to thank a man they once criticized for making the law possible: U.S. Supreme Court Chief Justice John Roberts. Senate Republicans added to t
11/18/17 - EKG on your smartphone? [Enid News & Eagle, Okla.]
Nov. 18 With your activity tracker, you can monitor your daily steps, calories consumed, heart rate and even your sleep patterns. That's all valuable health information, although your doctor may not want to be bombarded with reams of detail that may or may not be related to your medical conditions. It's a one-lead EKG, but the device has been pro
11/18/17 - EMA to work with stakeholders to improve the product information for EU medicines
LONDON, 15 November 2017/ PRNewswire Policy/ Stakeholder feedback sought on ongoing electronic initiatives. The European Medicines Agency has published an action plan to improve the product information for EU medicines, an information package for patients and healthcare professionals that accompanies every single medicine authorised in the EU and
11/18/17 - European Antibiotic Awareness Day: Statement by Guido Rasi, Executive Director of the European Medicines Agency
LONDON, 15 November 2017/ PRNewswire Policy/ Antibiotic resistance is on the rise worldwide. This also includes European Union bodies and institutions. Under the European Commission' s One Health Action Plan against Antimicrobial ResistanceExternal link icon, the European Medicines Agency works very closely with its sister agencies, the European
11/18/17 - FDA approves new drug to treat bleeding in hemophilia A patients [Tehran Times (Iran)]
The U.S. Food and Drug Administration today approved Hemlibra to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A who have developed antibodies called Factor VIII inhibitors. Today`s approval provides a new preventative treatment that has been shown to significantly reduce the number of bleeding
11/18/17 - FDA approves Roche potential haemophilia blockbuster [Tehran Times (Iran)]
The FDA has approved Roches highly-anticipated haemophilia drug, emicizumab, offering a more weekly dosing schedule and improved bleeding prevention than rivals from Bayer, Shire and Novo Nordisk. But this will come with the hefty price tag of $482,000 per year, falling to around $448,000 a year after that, making it one of the most expensive drugs
11/18/17 - FDA Approves Roche's Gazyva for Previously Untreated Advanced Follicular Lymphoma
Roche, a biotech company, issued the following news release:. Roche announced today that the US Food and Drug Administration approved Gazyva (R) in combination with chemotherapy, followed by Gazyva alone in those who responded, for people with previously untreated advanced follicular lymphoma. "Today's Gazyva approval is an important advance for t
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415